Market Tracker

07/31 6:01pm ET

Celgene Corp (NASDAQ:CELG)

131.25
Delayed Data
As of Jul 31
 -0.63 / -0.48%
Today’s Change
83.16
Today|||52-Week Range
140.72
+17.33%
Year-to-Date

Today’s Trading

Previous close131.88
Today’s open132.83
Day’s range130.77 - 133.00
Volume3,546,702
Average volume (3 months)4,628,242
Market cap$103.8B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+29.24%
Earnings growth (next 5 years)+24.56%
Revenue growth (last year)+17.89%
P/E ratio44.8
Price/Sales12.24
Price/Book16.10

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.15-0.34%
BMYBristol-Myers Squibb+1.18+1.83%
ABBVAbbVie-0.15-0.21%
LLYEli Lilly and Co-0.03-0.04%
Data as of 4:04pm ET, 07/31/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)$1.21
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts